ASX:BIT Biotron (BIT) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Biotron Stock (ASX:BIT) 30 days 90 days 365 days Advanced Chart Get Biotron alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.03 million shsAverage VolumeN/AMarket CapitalizationA$9.93 millionP/E RatioN/ADividend Yield5.08%Price TargetN/AConsensus RatingN/A Company Overview Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. The company was incorporated in 1999 and is based in Sydney, Australia. Read More Receive BIT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotron and its competitors with MarketBeat's FREE daily newsletter. Email Address BIT Stock News HeadlinesBiotron Advances Antiviral Programs with Successful Funding and Study CompletionJuly 28, 2025 | tipranks.comBiotron Limited Appoints Michael Medway as Non-Executive DirectorJuly 15, 2025 | tipranks.comThis rock I’m holding could be worth trillionsA strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.August 2 at 2:00 AM | Porter & Company (Ad)Biotron Ltd Stock Price History - Investing.comJune 26, 2025 | investing.comBiotron Advances Hepatitis B Drug Development with Successful Safety StudyJune 23, 2025 | tipranks.comBiotron Limited Announces Investor Webinar to Discuss Recent DevelopmentsMay 22, 2025 | tipranks.comBiotron Limited Advances Antiviral Commercialization with New Funding and Strategic PartnershipsApril 23, 2025 | tipranks.comBiotron Limited Announces Director’s Interest ChangeApril 9, 2025 | tipranks.comSee More Headlines BIT Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Biotron own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biotron investors own include TPG Co. Limited (TPM.AX) (TPM), Gemfields Group (GEM), Northern Star Resources (NST), Nokia (NOK), Mesoblast (MESO), Marathon Digital (MARA) and FYI Resources (FYI). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:BIT CIKN/A Webwww.biotron.com.au Phone61 2 9805 0488FaxN/AEmployees3Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$3.44 million Net Margins-208.89% Pretax MarginN/A Return on Equity-423.05% Return on Assets-94.68% Debt Debt-to-Equity Ratio-2.92 Current Ratio0.58 Quick Ratio2.32 Sales & Book Value Annual SalesA$1.65 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow6.71 Book ValueA$0.00 per share Price / BookN/AMiscellaneous Outstanding Shares902,310,000Free FloatN/AMarket CapA$9.93 million OptionableNot Optionable Beta-0.61 10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (ASX:BIT) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotron Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
